Clinical Edge Journal Scan

Prostate cancer: Surgery shows survival advantage in high-risk African Americans


 

Key clinical point: Radical prostatectomy vs external beam radiotherapy (EBRT) is associated with lower cancer-specific mortality in African American patients with National Comprehensive Cancer Network (NCCN) high-risk and Johns Hopkins University (JH) very high-risk prostate cancer.

Major finding: Radical prostatectomy and EBRT were performed in 39% and 61% of patients, respectively. Radical prostatectomy vs EBRT was associated with lower risk for cancer-specific mortality at 5 years in NCCN high-risk (2.3% vs 3.9%; hazard ratio [HR], 0.52; P = .02) and JH very high-risk patients (3.3% vs 7.4%; HR, 0.42; P = .02).

Study details: A retrospective study of 4,165 NCCN high-risk African American patients with prostate cancer identified from the Surveillance, Epidemiology, and End Results database between 2010 and 2016. Patients were subcategorized into JH high-risk (n=1,944) and very high-risk (n=2,221) groups.

Disclosures: No funding source was identified for this work. The authors declared no conflict of interests.

Source: Hoeh B et al. Prostate. 2021 Oct 18. doi: 10.1002/pros.24253 .

Recommended Reading

Metastatic prostate cancer: Chemotherapy use and survival have increased in recent years
Federal Practitioner
Prostate cancer: HDR brachytherapy boost linked to lower early toxicity rates
Federal Practitioner
Prostate cancer: SBRT safe in older patients with baseline anticoagulant use
Federal Practitioner
Clinical Edge Journal Scan Commentary: Prostate Cancer November 2021
Federal Practitioner
Urine test for prostate cancer signals amount of aggressive tumor
Federal Practitioner
Higher prostate cancer incidence in MSH2 and MSH6 carriers
Federal Practitioner
Prostate cancer: Salvage LDR brachytherapy after EBRT shows good response
Federal Practitioner
mCRPC: Enzalutamide effective in real-world setting
Federal Practitioner
Increase in PSA testing after 2017 USPSTF recommendations
Federal Practitioner
Prostate cancer screening: Racial disparities in MRI use after elevated PSA results
Federal Practitioner